<ѻý>Potential New First-Line Options for Unresectable Hepatocellular Carcinomaѻý> Tremelimumab-durvalumab improves OS, single-agent durvalumab non-inferior to sorafenib Jan 22, 2022
<ѻý>Fatty Liver Disease a Long-COVID Symptom After Severe Cases?ѻý> In Italian study, over half had metabolic dysfunction-associated fatty liver disease Jan 11, 2022
<ѻý>Is Weight Protective for NAFLD Patients Undergoing Transplant?ѻý> UNOS data showed differences in waitlist removal, all-cause mortality based on obesity status Nov 18, 2021
<ѻý>Hepatology Not Immune to Workplace Discriminationѻý> Women, racial/ethnic minorities most likely to experience discriminatory behavior Nov 17, 2021
<ѻý>Need for Liver Transplants Rising Sharply in Seniorsѻý> Post-transplant mortality still higher versus younger patients, but improving over time Nov 17, 2021
<ѻý>How Do Patients With Cirrhosis Respond to the COVID Vaccine?ѻý> Italian researchers examine data in this understudied subset of patients Nov 16, 2021
<ѻý>Blood-Based Biomarkers Prove Mettle in Liver Disease Diagnosisѻý> Data part of initiative to qualify biomarkers to help diagnose fibrosis or NASH Nov 15, 2021
<ѻý>FMT Benefits Last a Few Years in Severe Alcoholic Hepatitis Patientsѻý> More research needed to determine impact on clinical outcomes versus standard of care Nov 14, 2021
<ѻý>Simvastatin-Treated Liver Donors May Aid Transplant Patient Outcomesѻý> Improved graft survival versus placebo in small randomized trial Nov 14, 2021
<ѻý>How Did the COVID Pandemic Affect Liver Transplant Outcomes?ѻý> There was an impact on patient survival rates, but researcher acknowledges several confounders Nov 13, 2021
<ѻý>NASH Patients Are Entitled to a 'Bill of Rights'ѻý> Advocacy group encourages a "partnership" between clinicians and patients Nov 12, 2021
<ѻý>Injectable PH1 Therapy Also Effective in Advanced CKDѻý> Trial looked at patients with stages 3B through 5 chronic kidney disease Nov 07, 2021
<ѻý>Advanced Fibrosis Tied to Most Severe Outcomes in NAFLDѻý> Study found higher risk of liver decompensation, death in those with bridging fibrosis, cirrhosis Oct 20, 2021
<ѻý>Pan-PPAR Agonist 'Promising' for NASH Patientsѻý> But experts expressed concern over potential GI side effects Oct 20, 2021
<ѻý>A Cup of Joe to Thwart Liver Fibrosis? How About Fourѻý> Study finds protective benefit with high consumption, though not for fatty liver disease Oct 08, 2021
<ѻý>High-Dose HBV Revaccination Better Protects HIV Patientsѻý> Phase III trial saw more and longer-lasting responses with double the dose Aug 24, 2021
<ѻý>Can Liver Donor Biomarker Predict Liver Transplant Rejection?ѻý> Findings could support a patient-centered approach to liver transplantation, expert says Aug 23, 2021
<ѻý>Liver Transplant Sex Disparities Vanish With Living-Donor Accessѻý> Women who qualified for deceased donor organs had significantly worse MELD scores Aug 18, 2021
<ѻý>Herbal Weight-Loss Supplement Tied to Severe Liver Damageѻý> Garcinia cambogia and green tea led to clinically indistinguishable liver injury Aug 17, 2021
<ѻý>Time to Break the Abstinence Rule Before Liver Transplants?ѻý> Small study suggests alternative criteria to the "6-month rule" may be needed Aug 11, 2021
<ѻý>Ethics Consult: Is Oil Tycoon's Billboard for Liver Donor Ethical? MD/JD Weighs Inѻý> You voted, now see the results and an expert's discussion Jul 30, 2021
<ѻý>FDA Panel Nearly Unanimous on Liver Transplant Perfusion Deviceѻý> Thumbs up on safety and efficacy Jul 15, 2021
<ѻý>Academic Cardiologists Singled Out for Gender Equality Problemѻý> Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
<ѻý>Some Liver Transplant Patients Got Hepatitis B From Donorsѻý> Injection drug use may be mostly to blame, researcher says Jul 10, 2021
<ѻý>Cases of Rare Liver Complication Seen With Severe COVID-19ѻý> Higher prevalence of condition in COVID patients than influenza patients, researcher says Jul 01, 2021
<ѻý>Novel Liver Assist Device Safe for Patients With Cirrhosisѻý> Small preliminary trial also shows hints of promising clinical results Jun 29, 2021
<ѻý>Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Upѻý> Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
<ѻý>Food Insecurity Tied to More Liver Disease Deathsѻý> Social determinants of health play a key role, study found Jun 28, 2021
<ѻý>Dads With Obesity Mostly Cleared in Their Children's NAFLDѻý> U.K. study confirms it's mainly mom's fault Jun 28, 2021
<ѻý>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCCѻý> "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
<ѻý>Bulevirtide Shows Promise in Tough-to-Treat Hepatitis Dѻý> Significant responses seen with novel agent for "devil" disease Jun 27, 2021
<ѻý>Big Jump in Monthly Average Hospital Admission for Alcoholic Hepatitis Post-Pandemicѻý> Long-term impact of alcohol uptake on liver health during COVID-19 crisis remains unknown Jun 26, 2021
<ѻý>Liver Fibrosis Linked to Lower Response to COVID Vaccineѻý> Third dose may be needed in this population as well as some transplant patients, says researcher Jun 25, 2021
<ѻý>Rise in Alcohol Dependence Seen During Pandemicѻý> AUD in U.K. study tied to worse COVID outcomes and more mental health problems as well Jun 25, 2021
<ѻý>Liver Disease Tied to Increased Risk of Death From Severe COVIDѻý> French study of hospitalized patients also saw an increased risk of mechanical ventilation Jun 24, 2021
<ѻý>FDA Restricts Ocaliva Use in Primary Biliary Cholangitisѻý> Liver failure, need for liver transplant reported in patients with advanced cirrhosis May 27, 2021
<ѻý>Pandemic Drinking Took Swift Toll on the Gut, Liverѻý> Alcohol-related inpatient consults soared, remained high even after reopening May 14, 2021
<ѻý>Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer?ѻý> Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
<ѻý>FDA Panel Splits on Anti-PD-1 Monotherapy in HCCѻý> All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
<ѻý>Another FGFR Inhibitor Active in Bile Duct Cancersѻý> Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021